Lakefront Biotherapeutics | GLPG - Action





Action Changement Date
argenx SE USD 473.53M 132.91M 2025-12
AstraZeneca USD 6.57B 13M 2026-03
Biogen USD 1.95B 219.1M 2026-03
Genmab DKK 13M 1000K 2025-06
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
Incyte USD 115.62M 14.56M 2026-03
Merck EUR 4.56B 52M 2025-12
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.29B 17M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03